ReviewPharmacoEconomics2008

Methodological issues in evaluating cost effectiveness of adjuvant aromatase inhibitors in early breast cancer: a need for improved modelling to aid decision making.

Lieven AnnemansPubMed ↗Publisher ↗

No numbers read from the abstract.